metoncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre‐clinical model of human osteosarcoma-Reference-Cited by-同舟云学术

metoncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre‐clinical model of human osteosarcoma

Published:2009-07 Issue:3 Volume:218 Page:399-408
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

De Maria Raffaella,Miretti Silvia,Iussich Selina,Olivero Martina,Morello Emanuela,Bertotti Andrea,Christensen James G,Biolatti Bartolomeo,Levine Roy A,Buracco Paolo,Di Renzo Maria Flavia

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference40 articles.

1. Tyrosine kinase receptor indistinguishable from the c‐met protein;Giordano;Nature,1989

2. Scatter‐factor and semaphorin receptors: cell signalling for invasive growth;Trusolino;Nature Rev Cancer,2002

3. Met, metastasis, motility and more;Birchmeier;Nature Rev Mol Cell Biol,2003

4. c‐Met as a target for human cancer and characterization of inhibitors for therapeutic intervention;Christensen;Cancer Lett,2005

5. Drug development of MET inhibitors: targeting oncogene addiction and expedience;Comoglio;Nature Rev Drug Discov,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer;Veterinary Pathology;2023-10-31

2. Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients;Cells;2023-03-27

3. The mitotic regulator polo‐like kinase 1 as a potential therapeutic target for c‐Myc‐overexpressing canine osteosarcomas;Veterinary and Comparative Oncology;2022-08-23

4. A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells;OncoTargets and Therapy;2021-09

5. Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine;Frontiers in Veterinary Science;2021-05-17